Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GB226 |
Trade Name | |
Synonyms | Geptanolimab|GB-226|GB 226|CBT501|CBT-501|Genolimzumab |
Drug Descriptions |
Geptanolimab (GB226) is a monoclonal antibody that targets PD-1 (PDCD1) and inhibits binding of the PD-L1 (CD274) ligand, potentially resulting in enhanced anti-tumor immune response (PMID: 29932513, PMID: 33046518). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 122 |
CAS Registry Number | 2348469-43-0 |
NCIT ID | C148159 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GB226 | GB226 | 1 | 0 |